Antibody waning after immunosuppressive chemotherapy and immunomodulators, re-immunization considerations in pediatric patients with malignancy and chronic immune thrombocytopenic purpura

INTRODUCTION: Immunosuppressive chemotherapy increase the risk of vaccine-preventable infectious diseases in children; nevertheless, chemotherapy may result in delay or miss updated immunization schedules. The predictable antibody waning after incomplete primary immunization series may be intensifie...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdolkarimi, Babak, Amanati, Ali, Molavi Vardanjani, Hossein, ‏Jamshidi, Safura‏, Tabaeian, Seid Amir Pasha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335959/
https://www.ncbi.nlm.nih.gov/pubmed/35902837
http://dx.doi.org/10.1186/s12879-022-07647-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9335959/
https://www.ncbi.nlm.nih.gov/pubmed/35902837
http://dx.doi.org/10.1186/s12879-022-07647-1

Ejemplares similares